BTCS discloses liquidation risk on $54 million Aave loan in SEC filing

Editorial illustration: A glowing purple ether symbol suspended inside a metal clamp with a taut cable across its center, beside an amber warning triangle and blank folded paper.

In brief

  • BTCS reported about $54 million in Aave debt secured by its ether holdings.
  • BTCS listed roughly $111 million in crypto assets at an ETH price of $1,775.
  • Aave debt fell from about $64.1 million to $54 million between two filings.
  • BTCS sold ether below cost basis to keep its Aave health factor above the threshold.
  • No liquidations had occurred as of mid-November, according to the filings.

What the November 19 filing shows

BTCS reported approximately $54 million in debt on Aave, secured by its ether holdings. Against that debt, the company listed about $111 million in total crypto assets, valued at an ETH price of $1,775. It also reported $18 million in senior secured convertible notes (a separate layer of debt on top of its DeFi borrowing).

The reasoning in the filing is straightforward. BTCS said that because ether's price is unpredictable, it couldn't promise its collateral would avoid liquidation.

How the position changed in a week

An earlier quarterly filing on November 13 showed about $64.1 million in Aave debt as of November 9, backed by 46,676 ETH worth around $99.3 million at an ETH price of $2,127. That position carried an estimated health factor of about 1.24 and a liquidation threshold near $1,717 per ETH.

That $1,717 figure isn't today's trigger.

It applied to the larger $64.1 million debt load, and the current liquidation level depends on the present position. Between the two filings, BTCS cut its Aave debt from about $64.1 million to about $54 million, while the ETH price used for valuations fell from $2,127 to $1,775. The company sold ether below its cost basis to keep its health factor above the liquidation threshold, according to its filings as reported by Crypto Briefing.

How the Aave leverage works

The health factor measures how much room a position has before liquidation. As it falls toward the threshold, outside liquidators can sell the collateral to repay the loan. For ether, Aave typically allows a loan-to-value ratio of around 80%.

BTCS has used that defi credit line heavily. Since early 2025, its cumulative stablecoin borrowings on Aave reached about $152.4 million, of which roughly $89.4 million had been repaid. The loans mostly funded liquidity pool positions through the company's Imperium DeFi business, where it's been looking to earn yield on those borrowed stablecoins.

Cash on hand is thin. BTCS reported around $463,000 in cash at the end of September, according to its filings.

The company said it continues to monitor and adjust its borrowing positions as prices move. As of mid-November, it hadn't been liquidated.

Frequently asked questions

Has BTCS's Aave loan been liquidated?

No. BTCS's filings say no liquidations had occurred as of mid-November. The company said it continues to monitor and adjust its borrowing positions as prices move, but because ether's price is unpredictable it couldn't promise its collateral would avoid liquidation.

Is $1,717 per ETH the current liquidation price for BTCS?

Not necessarily. The roughly $1,717 threshold came from BTCS's November 13 quarterly filing and applied to the larger $64.1 million debt load as of November 9. BTCS has since cut its Aave debt to about $54 million, so the current trigger depends on the present position.

What is a health factor on Aave?

The health factor measures how much room a position has before liquidation. As it falls toward the threshold, outside liquidators can sell the collateral to repay the loan. BTCS's position carried an estimated health factor of about 1.24 as of November 9.